Metaglucina en es it fr

Metaglucina Brand names, Metaglucina Analogs

Metaglucina Brand Names Mixture

  • No information avaliable

Metaglucina Chemical_Formula


Metaglucina RX_link

No information avaliable

Metaglucina fda sheet

Metaglucina msds (material safety sheet)

Metaglucina MSDS

Metaglucina Synthesis Reference

No information avaliable

Metaglucina Molecular Weight

324.396 g/mol

Metaglucina Melting Point

188-190 oC

Metaglucina H2O Solubility

3430 mg/L

Metaglucina State


Metaglucina LogP


Metaglucina Dosage Forms

Tablet (250, 500 mg)

Metaglucina Indication

Used in the management of diabetes mellitus type 2 (adult-onset).

Metaglucina Pharmacology

Acetohexamide is an intermediate-acting, first-generation oral sulfonylurea. It lowers blood sugar by stimulating the pancreatic beta cells to secrete insulin and by helping the body use insulin efficiently. The pancreas must produce insulin for this medication to work. Acetohexamide has one-third the potency of chlorpropamide, and twice the potency of tolbutamide; however, similar hypoglycemic efficacy occurs with equipotent dosage of sulfonylureas.

Metaglucina Absorption

Rapidly absorbed from the GI tract.

Metaglucina side effects and Toxicity

Oral, rat LD50: 5 gm/kg; Oral, mouse LD50: >2500 mg/kg. Symptoms of an acetohexamide overdose include hunger, nausea, anxiety, cold sweats, weakness, drowsiness, unconsciousness, and coma.

Metaglucina Patient Information

No information avaliable

Metaglucina Organisms Affected

Humans and other mammals